CompoAtlas

Women's Whey Chocolate

Testo originale in francese.

Prodotto naturale per la salute autorizzato in Canada

Se questo prodotto fosse venduto in Francia

Nessun punto rilevato secondo le norme che applichiamo.

Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.

Composizione

Ingrediente medicinale e fontePer unità posologica, secondo la fonteMassimo giornaliero, adulto
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 90 % Whey protein

22.200 mgNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 70 mg Calcium

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 3.347 mg Glutamic acid

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 345 mg Glycine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 940 mg L-Alanine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 521 mg L-Arginine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 1.977 mg L-Aspartic acid

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 396 mg L-Cystine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 355 mg L-Histidine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 1.079 mg L-Isoleucine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 2.033 mg L-Leucine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 1.784 mg L-Lysine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 431 mg L-Methionine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 590 mg L-Phenylalanine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 1.090 mg L-Proline

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 955 mg L-Serine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 1.308 mg L-Threonine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 315 mg Tryptophan

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 547 mg L-Tyrosine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 1.099 mg L-Valine

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 17 mg Magnesium

Non precisataNon calcolata
Isolat de protéine de lactosérum

Fonte : Isolat de protéine de lactosérum

Potenza : 75 mg Potassium

Non precisataNon calcolata
Acide linoléique conjugué

Fonte : Acide linoléique conjugué

2.500 mgNon calcolata

Ingredienti non medicinali

Gomme de xanthane, Dark chocolate flavour, xylitol, Feuille de stevia rebaudiana, Cocoa Flavour, Chlorure de sodium, Saveur de chocolat

Dosi raccomandate in Canada

PopolazioneEtàQuantità per assunzioneFrequenza
AdultesNon précisée1 Mesures1 Tous les jours

Usi autorizzati in Canada

Source of (all) essential amino acids (i.e. histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine) for the maintenance of good health. Source of branched chain amino acids for the maintenance of good health. Source of (essential) amino acids involved in muscle protein synthesis. (Excellent) Source of protein for the maintenance of good health. (Excellent) Source of protein which helps build and repair body tissues. (Excellent) Source of proteins which helps build antibodies. Source of the minerals calcium, magnesium and phosphorus for the maintenance of good health. Source of potassium for the maintenance of good health. May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity. May help support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity.

Testo originale in inglese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Cautions and Warnings : Consult a health care practitioner prior to use if your goal is to achieve weight loss. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are obese or have cardiovascular disease (CVD) risk factors (e.g. high blood pressure, high cholesterol and/or triglycerides).

Testo originale in inglese.

Contra-Indications : If you have a milk allergy, do not use this product. Do not use if you have CVD, diabetes, metabolic syndrome or insulin resistance.

Testo originale in inglese.

Known Adverse Reactions : Some people may experience gastrointestinal upset.

Testo originale in inglese.

Scheda del prodotto

Altri nomi
PROTEINsmart, Wheysmart, Women's Whey, Women's Whey with CLA Chocolate Powder
Titolare
Jamieson Laboratories Ltd./ Nutricorp International
NPN o DIN-HM
80054110
Stato
Licenza attiva
Data della licenza
19 settembre 2014
Data di revisione
8 settembre 2026
Forma
Poudre
Via di somministrazione
Orale
Tipo di domanda
Non traditionnelle

Fonte

Scheda ufficiale Health Canada, licenza 80054110

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Testo originale in francese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

Avvertenze ufficiali (Health Canada)

Health Canada pubblica avvertenze su questi ingredienti:

  • Acide linoléique conjugué
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    CONJUGATED LINOLEIC ACID

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are obese or have cardiovascular disease (CVD) risk factors (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Basu et al. 2000a,b).

    Fonti citate da Health Canada (9)
    • Basu S, Risérus U, Turpeinen A, Vessby B. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clinical Science 99(6):511-516.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. The American Journal of Clinical Nutrition 79:1118-1125.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. The Journal of Nutrition 135(4):778-784.
    • Larsen TM, Toubro S, Gundmensen O, Astrup A. 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat gain. The American Journal of Clinical Nutrition 83(3):606-612.
    • Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. 2005. Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94(5):791-795.
    • Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. The Journal of Nutrition 137(5):1188-1193.
    • Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2):307-312.
    • Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. 2008. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. The Journal of Nutrition 138(8):1445-1451.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if your goal is to achieve weight loss.

    Controindicazioni

    Do not use if you are pregnant (HC 2010).

    Fonti citate da Health Canada (2)
    • HC 2010: Health Canada: Prenatal Nutrition Guidelines for health Professionals: Gestational weight gain [Accessed 2024 April 7]. Available from: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-eng.pdf
    • SC 2010 : Santé Canada : Lignes directrices sur la nutrition pendant la grossesse à l'intention des professionnels de la santé : Gain de poids pendant la grossesse. [Consulté le 7 avril 2024]. Disponible à : https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-fra.pdf

    Do not use if you have cardiovascular disease (CVD), diabetes, metabolic syndrome or insulin resistance (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Moloney et al. 2004; Basu et al. 2000a,b).

    Fonti citate da Health Canada (10)
    • Basu S, Risérus U, Turpeinen A, Vessby B. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clinical Science 99(6):511-516.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. The American Journal of Clinical Nutrition 79:1118-1125.
    • Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. The Journal of Nutrition 135(4):778-784.
    • Larsen TM, Toubro S, Gundmensen O, Astrup A. 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat gain. The American Journal of Clinical Nutrition 83(3):606-612.
    • Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM. 2004. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. The American Journal of Clinical Nutrition 80(4):887-895.
    • Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. 2005. Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94(5):791-795.
    • Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. The Journal of Nutrition 137(5):1188-1193.
    • Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2):307-312.
    • Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. 2008. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. The Journal of Nutrition 138(8):1445-1451.

    Reazioni avverse note

    When using this product you may experience gastrointestinal discomfort/disturbances (Gaullier et al. 2007; Pinkoski et al. 2006; Berven et al. 2000; Blankson et al. 2000).

    Fonti citate da Health Canada (4)
    • Berven G, Bye A, Hals O, Blankson H, Fagertun H, Thom E, Wadstein J, Gudmundsen O. 2000. Safety of conjugated linoleic acid (CLA) in overweight and obese human volunteers. European Journal of Lipid Science and Technology 102(7):455-462.
    • Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. 2000. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. The Journal of Nutrition 130(12):2943-2948.
    • Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
    • Pinkoski C, Chilibeck PD, Candow DG, Esliger D, Ewaschuk JB, Facci M, Farthing JP, Zello GA. 2006. The effects of conjugated linoleic acid supplementation during resistance training. Medicine and Science in Sports and Exercise 38(2):339-348.

    Monografia di Health Canada del 10 gennaio 2025

Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.

Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).

Il prodotto è cambiato? Fotografi la confezione.

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.

Invio per analizzare, Maiusc+Invio per una nuova riga